Assignee
VTV THERAPEUTICS LLC
US·47 granted patents·25 pending applications·174 citations·filing 2013–2025
Top patents by PatentIndex Score
72 records- 0195US10980861B2Glucokinase activator compositions for the treatment of diabetesVTV THERAPEUTICS LLC·Filed 2020·Granted Apr 20, 2021·4 cites·17 claims
- 0295US10952993B2Therapeutic uses of glucokinase activators in combination with insulin or insulin analogsVTV THERAPEUTICS LLC·Filed 2020·Granted Mar 23, 2021·5 cites·13 claims
- 0395US10287284B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2018·Granted May 14, 2019·14 cites·22 claims
- 0494US10947180B2Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonistsVTV THERAPEUTICS LLC·Filed 2019·Granted Mar 16, 2021·4 cites·11 claims
- 0593US11130753B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2020·Granted Sep 28, 2021·2 cites·29 claims
- 0693US10456406B2Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limbVTV THERAPEUTICS LLC·Filed 2018·Granted Oct 29, 2019·9 cites·11 claims
- 0793US9968613B2Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limbVTV THERAPEUTICS LLC·Filed 2016·Granted May 15, 2018·12 cites·14 claims
- 0893US9487493B2Use of a PPAR-delta agonist for treating muscle atrophyVTV THERAPEUTICS LLC·Filed 2014·Granted Nov 8, 2016·17 cites·20 claims
- 0992US11524942B2Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-phenoxy)-propyl]-diethyl-amineVTV THERAPEUTICS LLC·Filed 2021·Granted Dec 13, 2022·2 cites·7 claims
- 1092US9855274B2Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonistsVTV THERAPEUTICS LLC·Filed 2017·Granted Jan 2, 2018·7 cites·15 claims
- 1192US9393245B2Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2015·Granted Jul 19, 2016·7 cites·11 claims
- 1291US10471066B2Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonistsVTV THERAPEUTICS LLC·Filed 2017·Granted Nov 12, 2019·6 cites·10 claims
- 1390US11649230B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2021·Granted May 16, 2023·1 cites·29 claims
- 1490US11096946B2Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limbVTV THERAPEUTICS LLC·Filed 2019·Granted Aug 24, 2021·2 cites·10 claims
- 1590US10889580B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2020·Granted Jan 12, 2021·2 cites·20 claims
- 1690US10064846B2Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activatorVTV THERAPEUTICS LLC·Filed 2017·Granted Sep 4, 2018·6 cites·16 claims
- 1790US9855251B2Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activatorVTV THERAPEUTICS LLC·Filed 2016·Granted Jan 2, 2018·7 cites·16 claims
- 1889US10363244B2Compositions comprising metformin and a glucokinase activatorVTV THERAPEUTICS LLC·Filed 2018·Granted Jul 30, 2019·5 cites·1 claims
- 1988US10004782B2Glucokinase activator compositions for the treatment of diabetesVTV THERAPEUTICS LLC·Filed 2013·Granted Jun 26, 2018·10 cites·19 claims
- 2088US9663481B2Phenoxy acetic acids and phenyl propionic acids as PPARδ agonistsVTV THERAPEUTICS LLC·Filed 2013·Granted May 30, 2017·7 cites·15 claims
- 2188US9447468B2Compounds that modulate oxidative stressVTV THERAPEUTICS LLC·Filed 2013·Granted Sep 20, 2016·5 cites·12 claims
- 2287US10588943B2Glucokinase activator compositions for the treatment of diabetesVTV THERAPEUTICS LLC·Filed 2018·Granted Mar 17, 2020·5 cites·12 claims
- 2387US9707239B2Compounds that modulate oxidative stressVTV THERAPEUTICS LLC·Filed 2016·Granted Jul 18, 2017·3 cites·7 claims
- 2486US11974989B2Therapeutic uses of glucokinase activators in combination with insulin or insulin analogsVTV THERAPEUTICS LLC·Filed 2021·Granted May 7, 2024·1 cites·13 claims
- 2586US11833136B2Therapeutic uses of glucokinase activators in combination with insulin or insulin analogsVTV THERAPEUTICS LLC·Filed 2021·Granted Dec 5, 2023·1 cites·20 claims
- 2685US10568888B2Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2019·Granted Feb 25, 2020·2 cites·16 claims
- 2785US10463652B2Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereofVTV THERAPEUTICS LLC·Filed 2018·Granted Nov 5, 2019·4 cites·7 claims
- 2885US10391097B2Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2018·Granted Aug 27, 2019·2 cites·16 claims
- 2985US10172840B2Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereofVTV THERAPEUTICS LLC·Filed 2017·Granted Jan 8, 2019·4 cites·6 claims
- 3085US9717710B2Treatment of mild and moderate Alzheimer's diseaseVTV THERAPEUTICS LLC·Filed 2013·Granted Aug 1, 2017·5 cites·22 claims
- 3185US2025288681A1Solid compositions comprising a glucokinase activator and methods of making and using the sameVTV THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 3284US10898475B2Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereofVTV THERAPEUTICS LLC·Filed 2019·Granted Jan 26, 2021·2 cites·18 claims
- 3383US10570126B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2019·Granted Feb 25, 2020·2 cites·21 claims
- 3482US12391658B2Sulfoxide and sulfone glucokinase activators and methods of use thereofVTV THERAPEUTICS LLC·Filed 2021·Granted Aug 19, 2025·1 cites·17 claims
- 3581US2024245656A1Therapeutic uses of glucokinase activators in combination with insulin or insulin analogsVTV THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 3680US10085990B2Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2017·Granted Oct 2, 2018·1 cites·16 claims
- 3780US9833457B2Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2017·Granted Dec 5, 2017·1 cites·19 claims
- 3878US11420929B2Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonistsVTV THERAPEUTICS LLC·Filed 2021·Granted Aug 23, 2022·0 cites·5 claims
- 3978US10030011B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2014·Granted Jul 24, 2018·2 cites·33 claims
- 4078US9687489B2Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2016·Granted Jun 27, 2017·1 cites·11 claims
- 4177US10363241B2Substituted imidazole derivatives and methods of use thereofVTV THERAPEUTICS LLC·Filed 2018·Granted Jul 30, 2019·1 cites·3 claims
- 4276US11970457B2Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-phenoxy)-propyl]-diethyl-amineVTV THERAPEUTICS LLC·Filed 2022·Granted Apr 30, 2024·0 cites·12 claims
- 4376US11420942B2Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amineVTV THERAPEUTICS LLC·Filed 2020·Granted Aug 23, 2022·2 cites·17 claims
- 4476US2022072005A1Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type i muscle fibers in an immobilized limbVTV THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 4576US2025325536A1Therapeutic uses of glp1r agonistsVTV THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 4676US2026034107A1Substituted fused imidazole derivatives and methods of treating sickle cell disease and related complicationsVTV THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 4774US2026027090A1Methods of Inhibiting Osteoclastogenesis and Osteoclast ActivityVTV THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 4874US2022233701A1Solid compositions comprising a glucokinase activator and methods of making and using the sameVTV THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 4974US2025360139A1Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type i muscle fibers in an immobilized limbVTV THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 5069US2021069159A1Bach1 Inhibitors in Combination with Nrf2 Activators and Pharmaceutical Compositions ThereofVTV THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
Showing the top 50 of 72 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when VTV THERAPEUTICS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →